0001628280-24-011622.txt : 20240318 0001628280-24-011622.hdr.sgml : 20240318 20240318144928 ACCESSION NUMBER: 0001628280-24-011622 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20240318 FILED AS OF DATE: 20240318 DATE AS OF CHANGE: 20240318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CYBIN INC. CENTRAL INDEX KEY: 0001833141 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40673 FILM NUMBER: 24758532 BUSINESS ADDRESS: STREET 1: 100 KING STREET WEST STREET 2: SUITE 5600 CITY: TORONTO STATE: A6 ZIP: M5X 1C9 BUSINESS PHONE: (908) 764-8385 MAIL ADDRESS: STREET 1: 100 KING STREET WEST STREET 2: SUITE 5600 CITY: TORONTO STATE: A6 ZIP: M5X 1C9 6-K 1 cybininc-form6xk03x18x2024.htm 6-K Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of March, 2024.
Commission File Number: 001-40673


Cybin Inc.
(Exact Name of Registrant as Specified in Charter)

100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F Form 40-F ⊠







SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CYBIN INC.
(Registrant)
 
Date:March 18, 2024By:
/s/ Doug Drysdale    
Name:Doug Drysdale
Title:Chief Executive Officer





EXHIBIT INDEX


EX-99.1 2 a03-18x2024publicventuresd.htm EX-99.1 Document


image_0.jpg



Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas

TORONTO, CANADA – March 18, 2024 – Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced participation in the upcoming Public Ventures Discovery Day on March 19, 2024 in Dallas, TX.

Doug Drysdale, Chief Executive Officer of Cybin will participate in a fireside chat at the event and will be available to meet attendees during breakout sessions.

Public Ventures Discovery Day
Date: Tuesday, March 19, 2024
Presentation: 3:05 PM CST
Location: Pecan Room, Old Parkland, 3819 Maple Avenue, Dallas TX 75219

A video replay of the fireside chat will be available shortly after the conclusion of the event on the Company’s investor relations website on the Events & Presentations page.

Public Ventures, LLC, a wholly owned subsidiary of MDB Capital Holdings, LLC, (NASDAQ: MDBH), is the first invite-only investor community and self-clearing broker-dealer platform dedicated to backing visionary public companies with the potential to become market leaders in their technology category.

Discovery Day is a unique event for investors to learn about a curated group of venture-stage, deep-tech companies; share feedback and questions with company leaders; and connect with like-minded investors.

To register for Discovery Day, please email community@publicventures.com. Please note that spots are limited, and attendance preference will be given to existing MDBH shareholders.




About Cybin

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions.

Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The Company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds.

Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.cybin.com or follow the team on X, LinkedIn, YouTube and Instagram.

Investor & Media Contact: 
Gabriel Fahel
Chief Legal Officer
Cybin Inc.
1-866-292-4601
irteam@cybin.com – or – media@cybin.com



GRAPHIC 3 image_0.jpg GRAPHIC begin 644 image_0.jpg MB5!.1PT*&@H -24A$4@

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end